Sugammadex NDC 72205-479

NDC codes

FDA NDC Directory

Product NDC (as listed)72205-479Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72205-0479Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72205-479-02	72205047902	10 VIAL, SINGLE-DOSE in 1 CARTON (72205-479-02) / 5 mL in 1 VIAL, SINGLE-DOSE (72205-479-01)Marketed from Jul 28, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sugammadex
Generic name (nonproprietary): sugammadex
Active ingredients: Sugammadex sodium — 500 mg/5mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Novadoz Pharmaceuticals LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 214368
Marketing start: Jul 28, 2026
Listing expires: Dec 31, 2027
Other FDA classes: gamma-Cyclodextrins (Chemical structure)
Identifiers: Product ID 72205-479_63a0cffd-e2d7-4511-9ab8-923e26981e8eSPL ID 63a0cffd-e2d7-4511-9ab8-923e26981e8eSPL set ID ab41ea1c-266f-421c-8fc4-6e7ff518a75dRxCUI 1726992, 1727000UNII ERJ6X2MXV7UPC 0372205479012, 0372205478015, 0372205478022, 0372205479029

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N472205047902 followed by a unit qualifier and the quantity

Package 72205-0479-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 9, 2026.

Indications (excerpt from the label)

Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. Additional pediatric use information is approved for Merck Sharp & Dohme LLC’s BRIDION ® (sugammadex) injection. However, due to Merck Sharp & Dohme LLC’s marketing exclusivity rights, this drug product is not labeled with that information. Sugammadex injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 214368

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 214368
Product	Strength	Form · route	Labeler	Product NDC
Sugammadex	Sugammadex sodium 200 mg/2mL	Injection, SolutionIntravenous	Novadoz Pharmaceuticals LLC	72205-478